STUDY SEARCH RESULTS

369 studies found for your search request:  cancer

18F-FLT-PET in Breast Cancer (MK-0000-139)
Condition: Breast Cancer
Minimum Age: 35 years, Maximum Age: 75 years
Gender: Female
Study ID: NCT01015131
Status: Completed

A Clinical Study of Boserolimab (MK-5890) with Pembrolizumab and Chemotherapy in People with Early T...
Condition: Early triple negative breast cancer
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06829199
Status: Not yet recruiting

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Me...
Condition: Castration-Resistant Prostatic Cancer, Metastasis
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06863272
Status: Not yet recruiting

A clinical study of MK-2870 alone or with chemotherapy to treat gastrointestinal cancers (MK-9999-02...
Condition: Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06428409
Status: Recruiting
Has Enrolling Locations in US or Canada

A clinical study of Pembrolizumab (+) Berahyaluronidase alfa (MK-3475A) to treat newly-diagnosed met...
Condition: Lung Cancer, Non-Small Cell Lung Cancer
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06698042
Status: Recruiting
Has Enrolling Locations in US or Canada




Copyright © 2025 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site